Open Label Continuation Study in Moderate to Severe Psoriasis

Clinical trial NCT00626002 · COMPLETED

Trial details

NCT number: NCT00626002
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate to Severe Plaque Psoriasis

Start date: 2008-02-01
Primary completion: 2011-10-01
Enrollment: 2301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.